SUDAFED NON-DRYING SINUS OTC
Generic Name and Formulations:
Guaifenesin 200mg, pseudoephedrine HCl 30mg; per liquid cap.
McNeil Consumer Healthcare
Indications for SUDAFED NON-DRYING SINUS:
Nasal congestion and cough.
2 caps every 4 hours as needed; max 8 caps/24hrs.
Within 14 days of MAOIs.
Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Asthma. Lower respiratory disorders.
Expectorant + sympathomimetic.
Hypertensive crisis with MAOIs. β-blockers increase pressor effects of sympathomimetics. Antihypertensives antagonized.
Nervousness, dizziness, insomnia.
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness